Lindborg Stacy
CIK 0001813667
President and CEODirector
Filings
21
Latest May 27, 2026
Issuers covered
2
Showing
21 of 21
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -39.9% | -39.9% | +8.0% | -87.7% |
| 90 days | 2 | 0% | -53.9% | -53.9% | -25.0% | -82.8% |
| 180 days | 2 | 0% | -44.2% | -44.2% | -11.0% | -77.3% |
| 365 days | 2 | 0% | -66.6% | -66.6% | -50.9% | -82.2% |
Issuers
Companies where Lindborg Stacy has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IMNN | Imunon, Inc. | 14 | May 27, 2026 |
| BCLI | Brainstorm Cell Therapeutics Inc. | 7 | May 20, 2026 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|